Other news to note
Gloria Pharmaceuticals Co., of Beijing, and Cumberland Pharmaceuticals Inc., of Nashville, Tenn., formed a joint R&D initiative. Each company has made a $1 million investment in Cumberland Emerging Technologies (CET), which is majority-owned by Cumberland and partnered with academic research centers to develop promising biopharmaceutical technologies.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter